abstract |
Active compound (2R) -2-[[(4-chlorophenyl) sulfonyl] [[2-fluoro-4- (1,2,4-oxadiazol-3-yl) phenyl] methyl] amino] -5,5 , 5-trifluoropentanamide and polyethylene glycol (PEG) and vitamin E polyethylene glycol succinate and pharmaceuticals with or without citric acid, either polyvinylpyrrolidone (PVP) or copovidone (PVP-polyvinyl acetate) A capsule composition is provided. |